New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
09:02 EDTBDSI, ENDPBioDelivery Sciences could be bought by Endo, says Summer Street
Summer Street sees shares of BioDelivery Sciences (BDSI) heading to the $15 level on positive buprenorphine data in July, a drug the company partners with Endo (ENDP). The firm notes Endo could owe up to $70M in milestones to BioDelivery, but it finds it more likely that Endo buys BioDelivery outright. Summer Street keeps a Buy rating on the stock with a $20 price target.
News For BDSI;ENDP From The Last 14 Days
Check below for free stories on BDSI;ENDP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
10:02 EDTENDPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTENDPDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTENDPEndo initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 14, 2014
09:31 EDTENDPEndo upgraded to Conviction Buy from Buy at Goldman
July 11, 2014
11:19 EDTBDSIOptions with decreasing implied volatility: BDSI CWH INFY MONT
Subscribe for More Information
08:05 EDTENDPEndo recommended ahead of Q2 report at Morgan Stanley
Subscribe for More Information
July 10, 2014
11:01 EDTBDSIOptions with decreasing implied volatility: BDSI
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use